Background
Methods
Study population
Screening protocol
Results
CHD | Follow-up period | |||
---|---|---|---|---|
< 1 month | 1–6 months | 6 months to 2 years | > 2 years | |
Significant | ||||
ASD | 3 | 3 | ||
VSD | 12 | 2 | ||
PDA | 1 | 4 | ||
MR | 1 | 1 | ||
AR | 1 | 3 | ||
PS | 3 | |||
Non-significant | ||||
VSD | 2 | 11 | ||
PDA | 31 | 4 | ||
MR | 3 | 4 | ||
AR | 2 | 4 |
CHD | Screening method | Clinical findings | Age at intervention | Outcome | |
---|---|---|---|---|---|
Cardiac catheterization | Surgery | ||||
Critical CHD | |||||
SV | FUS | Cyanosis (SpO2: 30%) | - | 4 days | Alive |
SV & CoA | FUS | No | - | 15 days | Alive |
Serious CHD | |||||
TAPVC | PE | Heart murmur Cyanosis (SpO2: 91–94%) | - | 29 days | Alive |
PA & DORV | FUS | Heart murmur | - | 1 month | Alive |
AVSD | FUS | No | 2 months | 3 months | Alive |
TOF | PE | Heart murmur | - | 6 months | Alive |
TOF | FUS | Heart murmur | 4 months | 10 months | Alive |
TOF | PE | Heart murmur | 6 months | 10 months | Alive |
TOF | FUS | No | 7 months | 11 months | Alive |